Vol 6, Supplement 7 (October 24, 2017): Translational Cancer Research

Editorial

The importance of RET-directed therapy in patients with RET- rearranged non-small cell lung cancer

Kiyotaka Yoh

PDF Pages: S1121-S1123 Full Text (2573) Open Access

Mitochondrial calcium: a crucial hub for cancer cell metabolism?

Wolfgang F. Graier, Roland Malli

PDF Pages: S1124-S1127 Full Text (5302) COI Form Open Access

Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy

Vincent C. O. Njar

PDF Pages: S1128-S1131 Full Text (4566) Open Access

Immunotherapy in endometrial cancer: who are the most appropriate patients?

Katherine C. Kurnit, Amir A. Jazaeri

PDF Pages: S1132-S1135 Full Text (12534) Open Access

The future of prostate cancer precision medicine: anti-ERG therapies

Mani Roshan- Moniri, Michael Hsing, Paul S. Rennie, Artem Cherkasov, Michael E. Cox

PDF Pages: S1136-S1138 Full Text (4448) COI Form Open Access

BCL9L and caspase-2—new guardians against aneuploidy

Narendra Kumar Chunduri, Zuzana Storchova

PDF Pages: S1139-S1142 Full Text (2512) COI Form Open Access

Mighty RapaLink-1 vanquishes undruggable mutant mTOR in glioblastoma

Meena Jhanwar-Uniyal

PDF Pages: S1143-S1148 Full Text (4304) COI Form Open Access

Mixing, matching and modifying the prostate cancer microenvironment

Susan F. Slovin

PDF Pages: S1149-S1152 Full Text (2424) COI Form Open Access

Auto-antibodies against P53—a useful complementary biomarker for ovarian cancer screening?

Rudolf Kaaks, Renée T. Fortner

PDF Pages: S1153-S1157 Full Text (2579) COI Form Open Access

“Wonder drugs” in central nervous system lymphoma

Agnieszka Korfel

PDF Pages: S1158-S1162 Full Text (5755) Open Access

Fucosyltransferase 8 as a driver of melanoma metastasis: a new target for melanoma therapy?

Chi-Huey Wong, Tsui-Ling Hsu

PDF Pages: S1163-S1165 Full Text (1885) COI Form Open Access

Morphine, when used for treating patients with acute pancreatitis, could be more risky than previously suspected

Juan Iovanna, Maria Cecilia Mallmann

PDF Pages: S1166-S1168 Full Text (43267) COI Form Open Access

About rearranged during transfection in non-small cell lung cancer

Cesare Gridelli, Tania Losanno

PDF Pages: S1169-S1172 Full Text (2906) COI Form Open Access

Brigatinib, a new treatment option in ALK-rearranged advanced non-small cell lung carcinoma

Etienne Giroux Leprieur, Marie Wislez

PDF Pages: S1173-S1176 Full Text (2523) COI Form Open Access

Targeted therapies of HER2-positive gastric adenocarcinoma

Arik Bernard Schulze, Andrea Kerkhoff, Georg Lenz, Torsten Kessler

PDF Pages: S1177-S1180 Full Text (5761) COI Form Open Access

Liquid biopsies: envisioning a future when tissue is avoidable in lung cancer treatment decision-making

Noelia Vilariño, Roxana Reyes, Cristina Teixidó, Noemi Reguart

PDF Pages: S1181-S1186 Full Text (2676) COI Form Open Access

Overcoming resistance to third-generation epidermal growth factor receptor tyrosine kinase inhibitor in non-small cell lung cancer

Shoko Noda- Narita, Shintaro Kanda

PDF Pages: S1187-S1190 Full Text (5014) Open Access

Notch signalling: the true driver of small cell lung cancer?

Laure Marignol

PDF Pages: S1191-S1196 Full Text (6533) COI Form Open Access

Targeting glioblastoma stem-cells: a recurrent challenge in neurooncology

Giulia Berzero, Alberto Picca, Marc Sanson

PDF Pages: S1197-S1199 Full Text (2838) COI Form Open Access

Stereotactic conformal radiation therapy in the treatment of benign and low-grade brain tumors

James D. Byrne, Trevor J. Royce, Jay S. Loeffler

PDF Pages: S1200-S1204 Full Text (2714) COI Form Open Access

Targeting miR-155 in FLT3-ITD mutated AML: ready for prime time?

Edith Schneider, Arefeh Rouhi, Florian Kuchenbauer

PDF Pages: S1205-S1207 Full Text (2622) COI Form Open Access

Editorial on the use of immunotherapy in renal-cell carcinoma—promising results in combination therapy with ipilimumab and nivolumab

Christian Menzer, Carsten Gruellich, Jessica C. Hassel

PDF Pages: S1208-S1211 Full Text (2313) Open Access

Racial disparities in management of hepatocellular carcinoma

Andrea Mancuso

PDF Pages: S1212-S1214 Full Text (2303) COI Form Open Access

Finding a place for ceritinib in the landscape of ALK-positive nonsmall cell lung cancer

Elaine Shum, Leena Gandhi

PDF Pages: S1215-S1218 Full Text (2192) Open Access

Lipid transactions in cancer—the fat addiction and glycerol-3-phosphate acyltransferase action

Prashanth Panta, Bramanandam Manavathi

PDF Pages: S1219-S1224 Full Text (3221) COI Form Open Access

Nivolumab for chemorefractory oesophageal squamous cell carcinoma

Maxime Chénard-Poirier, Elizabeth C. Smyth

PDF Pages: S1225-S1228 Full Text (2186) Open Access

Advanced esophagogastric cancers: the making or breaking of a backbone

Asha Dhanarajan, Shelly Lo

PDF Pages: S1229-S1233 Full Text (9656) COI Form Open Access

Microphthalmia-associated transcription factors activate mTORC1 through RagD GTPase gene expression

Edith Jones, Ken Inoki

PDF Pages: S1234-S1238 Full Text (3111) COI Form Open Access

ONC201: a new treatment option being tested clinically for recurrent glioblastoma

Marie D. Ralff, Amriti R. Lulla, Jessica Wagner, Wafik S. El-Deiry

PDF Pages: S1239-S1243 Full Text (18455) Open Access

When better still might not be good enough

Waldemar Debinski

PDF Pages: S1244-S1247 Full Text (4290) COI Form Open Access

Optimal local therapy for early-stage small cell lung cancer: surgery needs a seat at the table

Kathryn E. Engelhardt, David D. Odell, Malcolm M. DeCamp

PDF Pages: S1248-S1252 Full Text (2357) COI Form Open Access

IDH mutational status and the immune system in gliomas: a tale of two tumors?

Bryan D. Choi, William T. Curry

PDF Pages: S1253-S1256 Full Text (5206) COI Form Open Access

Cancer relevance of signal recognition particle RNA and other non-coding RNAs in extracellular vesicles

Germana Rappa, Alice Conigliaro, Mark F. Santos, Riccardo Alessandro, Aurelio Lorico

PDF Pages: S1257-S1260 Full Text (2934) COI Form Open Access

Monitoring response to therapy by testing circulating tumor DNA in urine

Nicola Normanno

PDF Pages: S1261-S1263 Full Text (2421) COI Form Open Access

Switching gear and looking from a different angle in the treatment of HER2-positive disease

Kazuhiro Araki, Yasuo Miyoshi

PDF Pages: S1264-S1268 Full Text (2485) COI Form Open Access

Outcomes in BRCA mutation carriers: evaluation of current data for optimal clinical care

Ojas H. Vyas, Virginia G. Kaklamani

PDF Pages: S1269-S1272 Full Text (2275) COI Form Open Access

Identifying drivers of metastasis; towards a systematic approach

Michael R. Eccles, Aniruddha Chatterjee, Euan J. Rodger

PDF Pages: S1273-S1276 Full Text (3796) COI Form Open Access

Targeting sphingosine kinase 1 localization as novel target for ovarian cancer therapy

Caterina Bernacchioni, Paola Turano, Chiara Donati

PDF Pages: S1277-S1280 Full Text (2322) COI Form Open Access

Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?

Marco Mazzotta, Maddalena Barba, Laura Pizzuti, Patrizia Vici

PDF Pages: S1281-S1284 Full Text (3472) COI Form Open Access

Combining loco-regional treatments in early hepatocellular carcinoma: new achievements overcoming old limitations

Nelci Antunes de Moura, Fernando Gomes Romeiro

PDF Pages: S1285-S1287 Full Text (1832) COI Form Open Access

The optimal threshold for α-fetoprotein and vitamin K absence or antagonist-II is still an open issue

Shuixiang He, Junbi Hu, Yan Zhao

PDF Pages: S1288-S1290 Full Text (1843) COI Form Open Access

Letter to the Editor

Imaging of T cells in patients with recurrent glioblastoma

Sanjiv Sam Gambhir

PDF Pages: S1291-S1292 Full Text (3196) Open Access

Survival benefit of TACE combined with sorafenib for hepatocellular carcinoma patients with portal vein tumor thrombus

Bin Luo, Zhen-Hua Chen, Xiu-Ping Zhang, Meng Wang, Shu-Qun Cheng

PDF Pages: S1293-S1295 Full Text (1801) COI Form Open Access

Infusion-related reactions with administration of avelumab: mild and manageable side effects

James L. Gulley, Karen Kelly

PDF Pages: S1296-S1298 Full Text (5995) Open Access

Patterns of failure in head and neck cancer patients treated with intensity modulated radiation therapy: editorial response

Jonathan E. Leeman, Nancy Lee, Nadeem Riaz

PDF Pages: S1299-S1300 Full Text (2553) COI Form Open Access

Disclosure:

This supplement was published without any sponsorship or funding.